Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Brain disorder medtech rivals butt heads at ITC
Americas
Natus Medical retaliates against startup’s complaint in a patent clash over wearable diagnostic and monitoring products for neurological conditions.   27 August 2025
The right formula: Minimising the cost of chemical and pharma patents
Americas
From setting a clear overall strategy to drafting high-quality claims, Christopher Wheeler and Gerald Murphy of Birch, Stewart, Kolasch & Birch explain how to reduce patent prosecution expenditure and obtain better IP protection.   26 August 2025
‘This is not a rescue deal’: How an acquisition fits London firm's plan
Europe
The executive chair of Beck Greener enabled a smaller firm to swerve private equity and join its stable—a move that boosts what was already a "clear path to growth" under his bold leadership, discovers Sarah Speight.   26 August 2025
Careers
Bilingual litigator brings experience of handling IP disputes across multiple industries, from medical devices and pharmaceuticals to consumer electronics and apparel.   25 August 2025
Medtech
The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.   22 August 2025
Careers
‘One of the nation’s most accomplished ITC litigators” brought in to lead global practice at BigLaw firm.   22 August 2025
Americas
In a rare legal action, the medtech company claims the agency unlawfully let Apple reintroduce a feature on its watches that undermines an ITC ban.   21 August 2025
Medtech
The $4 billion-a-year orthodontics company says its latest lawsuits defend “critical components” of its portfolio as rivals push cheaper alternatives.   21 August 2025
Asia
Hui Zhuang of CCPIT Patent and Trademark Law Office discusses several strategies to increase the chance of pharmaceutical or food trademarks that include ingredients being registered.   21 August 2025
Europe
The Japanese pharma company has defended a key patent for a treatment that achieved record 2024 sales of over $6 billion—but a patent cliff looms.   20 August 2025